(Q43728696)

26 November 2017

Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression (English)

1 reference

26 November 2017

1 reference

2

Serretti A

1 reference

26 November 2017

8

Smeraldi E

1 reference

26 November 2017

Zanardi R

1

1 reference

26 November 2017

Rossini D

3

1 reference

26 November 2017

Franchini L

4

1 reference

26 November 2017

Cusin C

5

1 reference

26 November 2017

Lattuada E

6

1 reference

26 November 2017

Dotoli D

7

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

26 November 2017

Biological Psychiatry

1 reference

26 November 2017

50

1 reference

26 November 2017

323-330

1 reference

26 November 2017

5

1 reference

Efficacy and safety of fluoxetine in treating bipolar II major depressive episode.

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Practice guideline for major depressive disorder in adults. American Psychiatric Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Practice guideline for the treatment of patients with bipolar disorder. American Psychiatric Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake Inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

A comparison between delusional and non-delusional depressives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Serotonin transporter gene and manic depressive illness: An association study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Progress and pitfalls: bipolar molecular linkage studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial. Réseau de Recherche et d'Expérimentation Psychopharmacologique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Validity of subtyping psychotic depression: examination of phenomenology and demographic characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Lithium-responsive affective disorders: no association with the tyrosine hydroxylase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Delusional and nondelusional unipolar depression: further evidence for distinct subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

inferred from DOI database lookup

7 January 2021

based on heuristic

A functional variant of the serotonin transporter gene in families with bipolar affective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Psychotic depression: a separate entity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

PI, GC, HP, and TF serum protein polymorphisms in Siena, Tuscany, Italy, with a review of data for Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Delusional depression. A distinct clinical entity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Serotonin transporter gene and risk for bipolar affective disorder: an association study in Spanish population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Development of a Rating Scale for Primary Depressive Illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

MIXREG: a computer program for mixed-effects regression analysis with autocorrelated errors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Allelic Variation of Human Serotonin Transporter Gene Expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Serotonin transporter (5-HTT) gene polymorphisms are not associated with susceptibility to mood disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

AMITRIPTYLINE IN DEPRESSIVE STATES: PHENOMENOLOGY AND PROGNOSTIC CONSIDERATIONS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Depression, drugs, and delusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Clinical and neuropsychological comparison of psychotic depression with nonpsychotic depression and schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

The validity of major depression with psychotic features based on a community study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Delusional Depressions: Natural History and Response to Treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Is a single tricyclic antidepressant trial an active treatment for psychotic depression?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Serotonin transporter gene polymorphism and antidepressant response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Symptomatologic analysis of psychotic and non-psychotic depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Best estimate of lifetime psychiatric diagnosis: a methodological study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Behavioral effects of tryptophan depletion in seasonal affective disorder associated with the serotonin transporter gene?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Plasma tryptophan to large neutral amino acids ratio and therapeutic response to a selective serotonin uptake inhibitor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Analysis of a novel functional polymorphism within the promoter region of the serotonin transporter gene (5-HTT) in Brazilian patients affected by bipolar disorder and schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Late-life delusional depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Pindolol augmentation of treatment-resistant depressed patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Delusional unipolar depression: description and drug response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Pharmacogenetic response to antidepressants in a multicase family with affective disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Differentiation of two genetically specific types of depression by the response to anti-depressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Detection of symptomless postoperative deep vein thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Mode of inheritance in mood disorder families according to fluvoxamine response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Clinical and demographic features of psychotic and nonpsychotic depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Patterns of symptom improvement during antidepressant treatment of delusional depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

The search for genetic homogeneity in affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Outcomes on lithium treatment as a tool for genetic studies in affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Psychomotor symptoms of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

No association between chromosome-18 markers and lithiumresponsive affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

How long should pindolol be associated with paroxetine to improve the antidepressant response?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Efficacy of Paroxetine in Depression Is Influenced by a Functional Polymorphism Within the Promoter of the Serotonin Transporter Gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression: a controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901118-0

10.1016/S0006-3223(01)01118-0

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference